David Jenkins
- Senior Vice President, Head of Research & External Innovation
David joined Ipsen in 2018, with over 20 years of biotech and industry experience. He previously led TESARO’s immune-oncology translational research and development activities, advancing pioneering programs together with academic and industrial collaborators, as well as holding positions within Research and Development at AstraZeneca/MedImmune and Novartis. He received his MA PhD in Molecular Pharmacology from the University of Cambridge in the UK. At Ipsen, David oversees the external innovation strategy within research and development, focusing on partnership opportunities at all stages of `strategy across oncology, rare disease, and neuroscience. During his time with Ipsen, he has led numerous strategic partnerships that have driven its science-led external innovation strategy – accelerating treatments across established and emerging therapeutic areas at every stage of development.
